COVID-19 diagnostics for resource-limited settings: Evaluation of "unextracted" qRT-PCR.
COVID-19
RNA
RT-PCR
SARS-CoV-2
diagnostics
unextracted
Journal
Journal of medical virology
ISSN: 1096-9071
Titre abrégé: J Med Virol
Pays: United States
ID NLM: 7705876
Informations de publication
Date de publication:
01 2021
01 2021
Historique:
received:
12
05
2020
revised:
16
07
2020
accepted:
17
07
2020
pubmed:
12
8
2020
medline:
5
3
2021
entrez:
12
8
2020
Statut:
ppublish
Résumé
The coronavirus disease 2019 (COVID-19) pandemic has created a precipitous increase in the need for molecular diagnostics. Unfortunately, access to RNA extraction reagents can represent a bottleneck for quantitative real-time reverse transcriptase-polymerase chain reaction (qRT-PCR)-based methodologies, stemming from both extraordinary supply-chain stresses and the global reach of the virus into resource-limited settings. To provide flexible diagnostic options for such environments, we report here an "unextracted modification" for qRT-PCR using the Centers for Disease Control's (CDC's) widely utilized primers/probe sets for severe acute respiratory syndrome coronavirus 2 (N1/N2/N3 targeting viral nucleocapsid and RP-control targeting human RNase P). This approach replaces RNA extraction/purification with a heat-inactivation step of viral transport media (VTM), followed by direct inoculation-with or without VTM spin concentration-into PCR master mixes. Using derivatives of care from our clinical workflow, we compared traditional and unextracted CDC methodologies. Although some decrease in analytic sensitivity was evident (by higher C
Identifiants
pubmed: 32779772
doi: 10.1002/jmv.26328
pmc: PMC7405028
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
559-563Subventions
Organisme : NIAID NIH HHS
ID : R01 AI157827
Pays : United States
Organisme : NHGRI NIH HHS
ID : R42 HG009470
Pays : United States
Organisme : NHGRI NIH HHS
ID : R42HG009470
Pays : United States
Informations de copyright
© 2020 Wiley Periodicals LLC.
Références
Lancet. 2020 Feb 15;395(10223):470-473
pubmed: 31986257
Clin Infect Dis. 2020 Dec 17;71(10):2663-2666
pubmed: 32442256
mBio. 2020 Mar 26;11(2):
pubmed: 32217609
J Clin Microbiol. 1997 Feb;35(2):511-4
pubmed: 9003630
J Virol Methods. 2005 Mar;124(1-2):65-71
pubmed: 15664052
Nat Methods. 2020 May;17(5):465-468
pubmed: 32303725
Am J Clin Pathol. 2020 May 5;153(6):706-708
pubmed: 32227199
Euro Surveill. 2020 Apr;25(14):
pubmed: 32290902
JAMA. 2020 Apr 21;323(15):1437-1438
pubmed: 32150622
J Mol Diagn. 2019 Jul;21(4):623-631
pubmed: 31204166
Clin Chem. 2020 May 1;66(5):664-666
pubmed: 32077933
Lancet Microbe. 2020 May;1(1):e10
pubmed: 32835322
Ann Intern Med. 2020 Jun 2;172(11):726-734
pubmed: 32282894
J Med Virol. 2021 Jan;93(1):559-563
pubmed: 32779772
Emerg Microbes Infect. 2020 Dec;9(1):747-756
pubmed: 32196430